Croda Share Discussion Threads

[wad collector] 15/4/2024 09:50

Xd this week.

[wad collector] 29/2/2024 14:39

Everything down except debt! Surprised that share price has gone up, presumably worse was expected.

[battyliveson] 27/2/2024 07:49

Poor numbers, but probably expected given share price movements in last couple of years.

I think a fair value for croda is around £4.4 to £5.6bn, so will wait before I get back in.

B

[wad collector] 05/2/2024 16:38

Bouncing off £50 atm , maybe the worse is behind CRDA now, this is an industry with high barriers to entry , but still a long way back to the heady £100 days of 2021.

[wad collector] 14/12/2023 16:50

Thanks for that, the sharp share price rise suggests an impressive influence of the broker!

[smcni1968] 14/12/2023 14:02

Croda a long C-road to recoveryOperationally, a load C-road to recovery. We reduce Croda estimates c. 12% for FY24 and our target price to £53. In Consumer Care, we expect a sequential improvement in destocking; however, as demonstrated above, the overhang of inventories at HPC customers remains into the start of FY24. With a realignment of customer inventories globally still ongoing (esp. in Asia) and slower growth from large-cap customers more generally, the snap-back will not be immediate. This has raised and continues to raise debate around the defensiveness and quality of Croda's Consumer Care portfolio, given volume declines well in excess of even its lowest-quality peers, despite the cushioning from substantial growth in Iberchem.From an earnings perspective, even with stabilising volumes y/y, earnings remain impacted by operating deleverage and high-priced inventories. With it clear Ag end markets are unlikely to recover until H2. While volumes seem to be turning (Actives up y/y, Beauty Effects still negative) and despite work on inventories, we are not completely out of the woods, with inventories still above average. Risk therefore remains that the boost in volumes through September/October is short-lived near term, and thus, the outlook remains weak. We expect a weak 1H24 - essentially reflecting the 2H run rates, with a more meaningful improvement coming through as the year progresses.Strategically, poised but not yet able to catalyse growth given operational challenges. In the mid-term, Croda's less levered balance sheet than peers provides optionality from an acquisition perspective, with ND/EBITDA still c1x (at current EBITDA levels c1.4x). In the near term, the ability to acquire businesses remains constrained, with the attractive IFF Lucas Meyer assets too expensive, given current uncertainties in outlook and in managing the core business. Overall, that high-multiple stocks can get these deals executed at these multiples is another affirmation that multiples in the sector remain too high. For Croda to participate further in acquisitions, we believe a meaningful decline in industry multiples must be evident in asset prices.

[1retroz] 14/12/2023 08:48

Nice rise this morning. Apparently a report issued by Jefferies - has anyone seen yhe report?

[wad collector] 06/12/2023 16:38

Looks like the nadir has passed. Long way back up though...

[glennrcharles] 14/11/2023 14:44

I wonder whether the director's purchase is linked to the positive test results expected from the skinbiotix lysate expected soon.

[hope1815] 04/11/2023 08:26

Covering Croda and bought in on the 3 November at £44.45. It seems the chemical sector has been hit hard with Synthomer as an example but Croda is in profitability.

Croda, which is a major supplier of chemical ingredients to Estee Lauder and other cosmetics brands is seeing a decline in orders due to market conditions around the world. It is still in a good position to recover when orders pick up.

[fuji99] 23/10/2023 09:13

40% drop since the start of 2022.

[arja] 09/10/2023 14:31

got close to the 4170 chart support after the bad news but maybe it has bottomed at that point . Any trader quick on his or feet will have made heaps today if buying close to low point .

[pugugly] 09/10/2023 13:40

Woops - Croda cuts profit guidance as clients focus on reducing stockpiles
Croda now anticipates adjusted pre-tax profits of £300m to £320m this year
It is the second time in recent months that the firm has cut its profit outlook
The group's shares were the FTSE 100's worst performer on Monday morning
By HARRY WISE

Croda International has slashed its annual earnings outlook following a weaker-than-expected performance as its customers continued to destock their inventories.

The speciality chemicals provider now anticipates reporting adjusted pre-tax profits of £300million to £320million this year, down from previous guidance of between £370million and £400million.

It is the second profit warning the FTES 100 firm has delivered this year after declaring in June that earnings would be weaker than the £440million forecast by analysts.

[fuji99] 28/9/2023 08:40

Something definitely fundamentally wrong is brewing behind the scenes. I wouldn't touch it at the moment until this awful decay stops and clarifies.

[fuji99] 26/9/2023 11:53

Not good to see directors selling.

[fuji99] 20/9/2023 16:35

Games: Thanks a lot.

[qantas] 20/9/2023 15:57

Not anymore shorts doomed to failure hammering up.

Please do your own research as always.

[dancing piranha] 19/9/2023 16:36

A great short!

[commuter10] 19/9/2023 16:27

This gives real cause for concern as share price has now halved from Mid-2021 levels.

Is this a hold or sell share now do we think?

[games] 19/9/2023 13:04

Fuji99

Croda manufacture vaccine lipids

[games] 19/9/2023 13:01

Read 3rd paragraph and concerns cancer etc

Wafik S md comment (tweet) embedded on page above. His wiki credentials are listed further below

Ref lipid

This is meant to be a growth market

Phillip B & Kevin M with others have worked thoroughly on the contamination issues. They used oxford nanopore kit

Btw this discovery may also become heredity

[fuji99] 19/9/2023 12:47

I cannot see this is related to Croda.

[games] 19/9/2023 12:22

Maybe have a read of this.

Senate hearing, contamination

Ref lipids, note the concerns

Add this to other segments of croda with weak forecasts

This has been an evolving story.

[fuji99] 13/9/2023 12:27

A steep decline for now weeks may have a reason behind it.